Coronavirus
-
Covid-19 may come back in a few years, study says
Schools are closed, streets are sparse, and people are kept apart --this may become a new normal for a long time.
-
Dog may be intermediate host for new coronavirus, study says
Since the outbreak of the new coronavirus pneumonia Covid-19, more and more experimental teams around the world have joined the traceability team to try to understand how the new coronavirus that caused the outbreak was transmitted from animal hosts to humans.
-
China's Covid-19 vaccine enters Phase II clinical trial, first in the world
The adenovirus vector recombinant coronavirus vaccine developed by the team of academician Chen Wei of the Institute of Military Engineering, Chinese Academy of Military Sciences, launched the second-phase clinical trial on April 12, according to CCTV News.
-
COVID-19 is strongly related to temperature, research shows
The latest research shows that seasonal temperature changes may affect the propagation trajectory of COVID-19 in different parts of the world.
-
Another coronavirus vaccine in China will enter clinical trials
Phase I/II clinical trials of the new coronavirus (COVID-19) inactivated vaccine (Vero cells) developed by Sinopharm Group China Wuhan Bioproducts Research Institute Co., Ltd. are in pre-registration of "passed review" at the China Clinical Trial Registration Center status.
-
Explainer: What is asymptomatic infection
At present, the spread of new local coronavirus in China has been basically stopped, but the asymptomatic infection of new coronavirus has attracted much attention.
-
What role does immunity play in treatment of Covid-19?
On the evening of April 9, Cao Xuetao, academician of the Chinese Academy of Engineering and president of Nankai University, published a review article entitled "Immunopathology of New Coronavirus Pneumonia and Its Implications for Treatment" in the "Nature-Immunology Review" online.
-
What is the impact of the new coronavirus mutation?
In the global action against the new coronavirus pneumonia epidemic, mankind has learned more and more about this deadly virus.
-
Remdesivir clinical trials on critical patients in China terminated due to data limitations
New England Medicine magazine released the first clinical research results of Remdesivir in the treatment of severe patients with new coronavirus pneumonia on Friday. Most patients have achieved clinical improvement, but the data of these sympathetic medications have limitations.
-
Softbank to provide Japan with 300 million free masks made by BYD each month
Masayoshi Son, CEO of SoftBank Group, said that after reaching an agreement with Chinese electric vehicle manufacturer BYD, he has ensured that 300 million masks will be supplied to Japan every month from May.